Aztreonam: Difference between revisions

Line 53: Line 53:
==Contraindications==
==Contraindications==
*Allergy to class/drug
*Allergy to class/drug
*See also Special Populations section


==Adverse Drug Reactions==
==Adverse Drug Reactions==

Revision as of 22:17, 27 February 2014

General

  • Type: Monobactam
  • Dosage forms: IM; IV
  • Common Trade Names: Azactam

Other

  • Antimicrobial activity more closely resembles AG's (only active against gram -)
    • Enterobacter, pseudomonas, H. influenzae, gonococci
    • Little allergic cross-reactivity with B-lactam antibiotics

Adult Dosing

General (Moderate Severe)

  • 1-2g IM/IV q8-12h
  • Max: 8g/day

General (Severe)

  • 2g IM/IV q6-8h
  • Max: 8g/day

Pediatric Dosing

General (Neonates)

  • <7 days old
    • <2000g
      • 60 mg/kg/day IV divided q12h
      • First ED Dose: 30 mg/kg x 1
    • >2000g
      • 90 mg/kg/day IV divided q8
      • First ED Dose: 30 mg/kg x 1
  • 7 days - 1 month
    • <1200g
      • 60 mg/kg/day IV divided q12h
      • First ED Dose: 30 mg/kg x 1
    • 1200-2000g
      • 90 mg/kg/day IV divided q8
      • First ED Dose: 30 mg/kg x 1
    • >2000g
      • 120 mg/kg/day IV divided q6
      • First ED Dose: 30 mg/kg x 1

General (1 Month - 9 Months)

  • General
    • 90-120 mg/kg/day IV divided q6-8h
    • First ED Dose: 40 mg/kg x 1
  • Respiratory Infections in Cystic Fibrosis
    • 200mg/kg/day IV divided q6h
    • First ED Dose: 40 mg/kg x 1
    • Max: 8g/day

General >9 Months)

  • 90-120 mg/kg/day IV divided q6-8
  • First ED Dose: 40 mg/kg x 1

Contraindications

  • Allergy to class/drug
  • See also Special Populations section

Adverse Drug Reactions

Serious

Common

  • Phlebitis
  • Injection site reaction
  • Diarrhea
  • Nausea/vomiting
  • Rash
  • Transaminitis
  • Elevated creatinine
  • Eosinophilia

Pharmacology

  • Half-life: 1.7h (4.7-6h ESRD)
  • Metabolism: CYP450, minimal liver
  • Excretion: Urine
  • Mechanism of Action: Bactericidal; inhibits cell wall synthesis

Special Populations

  • Pregnancy: B
  • Lactation: Safe
  • Renal
    • Adult
      • CrCl 10-30: 1-2g x1, then decrease dose 50%
      • CrCl <10: give usual dose x1, then decrease dose 75%
      • Hemodialysis: give 12.5% of initial dose as supplement
      • Peritoneal dialysis: no supplement
    • Pediatric
      • CrCl 10-30: decrease dose 50%
      • CrCl <10: decrease dose 75%
      • Hemodialysis: give supplement
      • Peritoneal dialysis: no supplement
  • Hepatic (Adult & Pediatric)
    • caution advised, but not defined

See Also

Source

  • Epocrates